Effectiveness of Depression and Substance Use Module for Patients With Co-occurring Disorders
D-SUD-M
Adaptation And Effectiveness Of Depression And Substance Use Module For Patients With Substance Use Disorders And Depression in Pakistan
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to evaluate the adaptation and effectiveness of an integrated treatment module, the Depression and Substance Use Disorder Module (D-SUD-M), for male patients experiencing co-occurring depression and substance use disorders in Pakistan. Participants are divided into two groups: an experimental group receiving the structured D-SUD-M intervention-based sessions and a control group receiving standard routine treatment sessions within the rehabilitation center. The primary objective is to evaluate whether the specialized intervention module significantly reduces depressive symptoms and substance use severity compared to routine standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started May 2026
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2026
CompletedFirst Submitted
Initial submission to the registry
July 10, 2026
CompletedFirst Posted
Study publicly available on registry
July 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
CompletedJuly 16, 2026
July 1, 2026
5 months
July 10, 2026
July 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in symptoms severity of depression from baseline to post-intervention
Assessed using the Beck Depression Inventory (BDI-II). The BDI-II is a 21-item self-report scale measuring characteristics and symptoms of depression. Total scores range from 0 to 63, with higher scores indicating a worse outcome (greater depressive symptom severity).
Baseline to Post-intervention (5months) total weeks(22)
Change in Substance Use Disorder Severity from baseline to post-intervention
Assessed using the Drug Abuse Screening Test (DAST-10). The DAST -10 is a self-report instrument used to evaluate consequences related to drug misuse. Total scores range from 0 to 10, with higher scores indicating a worse outcome (greater severity of substance use-related problems).
baseline to post-intervention (5months), total weeks (22)
Study Arms (2)
Experimental Group: Treatment Module D-SUD-M
EXPERIMENTALParticipants in this group will recieve special treatment module D-SUD-M for patients with Depression and Substance Abuse.
Control Group
ACTIVE COMPARATORNo exposure of special treatment module will be given to the participants of this group.
Interventions
A specialized psychological Intervention based module design for reducing the symptoms and to check the effectiveness of module on patients with depression and substance use disorder. This module is translated and culturally adapted. A manual treatment booklet was written in which eclectic approaches were used like Behaviour therapy, Cognitive behaviour therapy, relapse prevention, group therapy along with activity sheets for each session. 12 intervention based sessions will be given to the participants of this group.
No module based treatment will be given to the participants of this group.
Eligibility Criteria
You may qualify if:
- Participants identified by the rehabilitation centre
- Only male participants will be taken,
- Age range lies between 17 to 56 years,
- Screening of depression by using the Beck Depression Inventory (BDI-II) and for Substance Use Disorders using Drug Abuse Screening Test (DAST-10),
- Diagnosed patients based on DSM-5 clinical diagnostic criteria will be taken into study.
You may not qualify if:
- Diagnosed cases of other psychopathology including bipolar disorder, psychotic depression, and others will not be taken in study,
- Cases of cognitive impairment linked to physical illness will not be part of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Najjat Trust
Rawalpindi, Punjab Province, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 10, 2026
First Posted
July 15, 2026
Study Start
May 2, 2026
Primary Completion
September 30, 2026
Study Completion
September 30, 2026
Last Updated
July 16, 2026
Record last verified: 2026-07